Genomic alterations and phenotype of large compared to small high-grade ductal carcinoma in situ.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Human Pathology

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.humpath.2011.01.002PMID 21496874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

  2010cited by this paper
• Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

  2008cited by this paper
• Immunohistochemical categorisation of ductal carcinoma in situ of the breast

  2007cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2007cited by this paper
• Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

  2007cited by this paper
• Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS

  2007cited by this paper
• Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ.

  2006cited by this paper
• HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy

  2005cited by this paper
• The molecular genetics of breast cancer: the contribution of comparative genomic hybridization.

  2005cited by this paper
• Molecular evolution of breast cancer

  2005cited by this paper
• A comparison study: applying segmentation to array CGH data for downstream analyses

  2005cited by this paper
• Mast cell and macrophage counts and microvessel density in invasive breast carcinoma-comparison analysis with clinicopathological parameters.

  2005cited by this paper
• Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors.

  2005cited by this paper
• Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

  2005cited by this paper
• Cyclin D1 in Breast Cancer

  2004cited by this paper
• Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ

  2004cited by this paper
• Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

  2004cited by this paper
• Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Assembly of microarrays for genome-wide measurement of DNA copy number

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors.

  2001cited by this paper
• Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

  1999cited by this paper
• Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways

  1999cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.

  1999cited by this paper
• Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia

  1998cited by this paper
• Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.

  1998cited by this paper
• Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

  1997cited by this paper
• A prognostic index for ductal carcinoma in situ of the breast

  1996cited by this paper
• Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

  1996cited by this paper
• Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.

  1996cited by this paper
• Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.

  1994cited by this paper
• Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.

  1992cited by this paper
• Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry

  1990cited by this paper
• Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis

  1988cited by this paper

• Genomic landscape of ductal carcinoma in situ and association with progression

  2019cites this paper
• INVESTIGATING INVASION IN DUCTAL CARCINOMA IN SITU WITH TOPOGRAPHICAL SINGLE CELL GENOME SEQUENCING

  2018cites this paper
• Genome evolution in ductal carcinoma in situ: invasion of the clones

  2017influential citation
• Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast

  2015cites this paper
• Copy number analysis of ductal carcinoma in situ with and without recurrence

  2015cites this paper
• Large palpable ductal carcinoma in situ is Her-2 positive with high nuclear grade.

  2015cites this paper
• A Novel, Patient-Specific Mathematical Pathology Approach for Assessment of Surgical Volume: Application to Ductal Carcinoma in situ of The Breast

  2011cites this paper